Federated Hermes’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-44,807
| Closed | -$293K | – | 2100 |
|
2023
Q4 | $293K | Sell |
44,807
-189,696
| -81% | -$1.24M | ﹤0.01% | 1456 |
|
2023
Q3 | $2.35M | Buy |
234,503
+22,027
| +10% | +$220K | 0.01% | 874 |
|
2023
Q2 | $2.64M | Sell |
212,476
-13,148
| -6% | -$163K | 0.01% | 869 |
|
2023
Q1 | $3.16M | Sell |
225,624
-18,262
| -7% | -$256K | 0.01% | 813 |
|
2022
Q4 | $3.49M | Buy |
243,886
+186,467
| +325% | +$2.67M | 0.01% | 760 |
|
2022
Q3 | $1.47M | Buy |
57,419
+21,016
| +58% | +$537K | ﹤0.01% | 998 |
|
2022
Q2 | $1.03M | Buy |
36,403
+36,036
| +9,819% | +$1.02M | ﹤0.01% | 1134 |
|
2022
Q1 | $13K | Sell |
367
-23,360
| -98% | -$827K | ﹤0.01% | 1867 |
|
2021
Q4 | $994K | Sell |
23,727
-63,614
| -73% | -$2.66M | ﹤0.01% | 1275 |
|
2021
Q3 | $4.29M | Buy |
87,341
+37,599
| +76% | +$1.85M | 0.01% | 856 |
|
2021
Q2 | $2.08M | Buy |
+49,742
| New | +$2.08M | ﹤0.01% | 1083 |
|
2021
Q1 | – | Sell |
-20,000
| Closed | -$561K | – | 2310 |
|
2020
Q4 | $561K | Buy |
+20,000
| New | +$561K | ﹤0.01% | 1497 |
|